Biotherapeutics Cell Line Development Strategic Business Research Report 2024-2030: Rising Investments in Biosimilar Development Creating New Opportunities [Yahoo! Finance]
Danaher Corporation (DHR)
Last danaher corporation earnings: 1/30 06:00 am
Check Earnings Report
US:NYSE Investor Relations:
investors.danaher.com
Company Research
Source: Yahoo! Finance
Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The global market for Biotherapeutics Cell Line Development was estimated at US$99.0 Million in 2023 and is projected to reach US$150.7 Million by 2030, growing at a CAGR of 6.2% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The growth in the biotherapeutics cell line development market is driven by several factors, including the rising demand for biologic drugs, advancements in gene editing technologies, and the increasing focus on personalized medicine. The need for efficient, scalable production processes for monoclonal antibodies, biosimilars, and gene therapies is a key driver of market growth. Additionally, the adoption of automation and AI in cell line selection and optimization is enhancing productivity and reducing development timelines. The regulatory push for faster a
Show less
Read more
Impact Snapshot
Event Time:
DHR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DHR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DHR alerts
High impacting Danaher Corporation news events
Weekly update
A roundup of the hottest topics
DHR
News
- Coding & Marking Equipment Industry Forecast Report, 2025-2030: Emerging Trends, Opportunities, Regional Market Insights, Competitive Intelligence [Yahoo! Finance]Yahoo! Finance
- The ‘North Star' Is 46 Times Bigger Than The Sun And ‘Spotty', Scientists Say [Forbes]Forbes
- $55.7 Billion Biopharmaceutical Fermentation Systems Market Opportunities and Strategies to 2033: Development of New Bioreactors to Enhance Single-Use Upstream Operations, New Technology Developments [Yahoo! Finance]Yahoo! Finance
- [Latest] Global Pharmaceutical Membrane Filtration Market Size/Share Worth USD 27,620 Million by 2033 at a 13.4% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value) [Yahoo! Finance]Latest
- Single-Use Bioreactors Market Forecast to Reach $9.1 Billion by 2029, at a CAGR of 15.4% - Comprehensive Analysis by Product, Type, Molecule, Cell Type, Application and Region [Yahoo! Finance]Yahoo! Finance
DHR
Earnings
- 10/22/24 - Beat
DHR
Sec Filings
- 11/22/24 - Form 4
- 11/22/24 - Form 4
- 11/22/24 - Form 4
- DHR's page on the SEC website